COVID-19
COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.
COVID-19 infection accelerates disease progression in children and adolescents with presymptomatic type 1 diabetes.
Jason Okulicz, of Gilead Sciences, discusses a study that showed remdesivir reduces mortality in elderly patients with COVID.
Heart failure patients who are vaccinated against COVID-19 have a considerably greater likelihood of living longer.
Men with type 2 diabetes have higher rates of recorded long COVID.
Dr. Bob Walker discusses high blood pressure in the context of severe COVID-19 infection.
Advertisement
Expert Interviews on COVID-19
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.